ABSTRACT We engineered metal-phenolic capsules with both high targeting and low nonspecific cell binding properties. The capsules were prepared by coating phenol-functionalized hyaluronic acid (HA) and poly(ethylene glycol) (PEG) on calcium carbonate templates, followed by cross-linking the phenol groups with metal ions and removing the templates. The incorporation of HA significantly enhanced binding and association with a CD44 overexpressing (CD44+) cancer cell line, while the incorporation of PEG reduced nonspecific interactions with a CD44 minimal-expressing (CD44-) cell line. Moreover, high specific targeting to CD44+ cells can be balanced with low nonspecific binding to CD44-cells simply by using an optimized feed-ratio of HA and PEG to vary the content of HA and PEG incorporated into the capsules. Loading an anticancer drug (i.e., doxorubicin) into the 2 obtained capsules resulted in significantly higher cytotoxicity to CD44+ cells but lower cytotoxicity to CD44-cells.
INTRODUCTION
Conventional chemotherapy can lead to the indiscriminate distribution of anti-cancer drugs, which can cause harmful side-effects in healthy cells and tissue. [1] [2] [3] Hence, it is critical to develop drug delivery systems that can specifically bind to diseased cells, while avoiding interactions with normal, healthy cells. 4, 5 A variety of biomacromolecules, including hyaluronic acid (HA), [6] [7] [8] folic acid, 9 peptides, 10 and monoclonal antibodies 11 have been developed as targeting ligands for selective receptors on carcinoma cells. HA, a benign, biodegradable, naturally occurring polysaccharide, has been extensively combined with drug carriers because it has a high binding affinity toward its primary receptor, CD44, which is over-expressed on different types of cancer cells (e.g., breast, ovarian, and lung cells). [12] [13] [14] [15] However, HA-based carriers can also have non-specific interactions with normal cells; this reduces the targeting specificity toward cancers. For example, the immobilization of HA on liposomes compromises the in vivo circulation time, leading to lower tumor-site accumulation. 16 One way to address this issue is to incorporate low-fouling materials, such as poly(ethylene glycol) (PEG), 17, 18 into targeted carriers to avoid non-specific interactions with healthy cells, and thereby reduce immune responses and prolong in vivo circulation.
However, the low-fouling nature of PEG can also hinder cellular recognition and active targeting by limiting the interactions between HA and CD44 receptors. 19 Therefore, a balance between reducing non-specific interactions and promoting active targeting needs to be considered when designing targeted drug delivery carriers.
3
Capsules are a versatile drug delivery system due to their tunable composition and structure, and the high degree of control over their degradation and cargo release properties. 20, 21 Recently, we reported a simple and rapid strategy to assemble metal-phenolic network (MPN) capsules based on the coordination between polyphenols and metal ions. 22 By varying the incorporated metal ions, the MPN capsules were endowed with diverse
properties and were applied in drug delivery, diagnostic imaging, and catalysis. 23, 24 Furthermore, by using a synthetic PEG-polyphenol (PEGp) as a building block, MPN capsules resistant to non-specific protein adsorption and cell adhesion were engineered. 25 Although MPN capsules represent a promising platform for drug delivery, the development of MPN capsules showing high targeting efficacy remains unexplored.
Herein, we engineer MPN HA-PEG capsules, consisting of targeting ligands (HA) and lowfouling PEG, both functionalized with phenolic moieties, for tunable cancer cell targeting.
The assembly of the MPN HA-PEG capsules is driven by metal-phenol coordination, which provides an easy and rapid approach to incorporate multiple components into one capsule was added. The mixture was stirred at room temperature under argon atmosphere for 20 h.
The resultant product was purified by dialysis (3.5 kDa regenerated cellulose membrane;
Thermo Fisher Scientific, USA) for three days against 5 L of degassed acidic water (pH 3.5),
and then collected by lyophilization as a white powder.
To fluorescently label the PEGp, AF488 cadaverine (0.64 mg, molar ratio of PEG/AF488-cadaverine 20:1) in anhydrous DMSO (1 mg mL -1 ) was added into 8-arm-PEG-NHS solution.
Subsequently, dopamine and TEA were added and incubated for 20 h as described above. (1 mg mL -1 ), and 4 mL of aqueous TRIS buffer solution (20 mM, pH 8.5) were successively added to the aqueous CaCO 3 particle suspension at room temperature, followed by vigorous stirring for 2 min after each addition. Subsequently, the particles were washed three times with water with centrifugation (3000 g, 3 min)/redispersion steps, and incubated with aqueous EDTA solution (100 mM, pH 7.5) for 1 min at room temperature to dissolve the The degree of modification was 3-4%, as determined by UV-Vis spectroscopy using the characteristic catechol absorption peak at 280 nm ( Figure S2 ), which is consistent with previous reports. 26, 28 The catechol content was further confirmed with Table S1 ). The higher resultant ratio (than feed ratio) suggests that HAp incorporates into the MPN capsules to a greater extent, probably due to its larger molecular weight and negative charge. Capsules composed solely of HAp (MPN HA capsules) and PEGp (MPN PEG capsules) were also synthesized and characterized ( Figure S5a-c, m-o ). There were 10 fg of HAp and 9 fg of PEGp incorporated into a single MPN HA and MPN PEG capsule, respectively (Table S1 ). Table S1 ). We hypothesize the contact between HA and CD44 receptors was inhibited by the hydration layer that is likely to form around PEG. 35 Therefore, when designing HA-based carriers for effective targeted drug delivery, the HA:PEG ratio should be carefully considered and tuned. 
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